8-K//Current report
SAB Biotherapeutics, Inc. 8-K
Accession 0001193125-25-220721
$SABSCIK 0001833214operating
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 4:45 PM ET
Size
495.6 KB
Accession
0001193125-25-220721
Documents
- 8-Ksabs-20250926.htmPrimary
8-K
- EX-10.1sabs-ex10_1.htm
EX-10.1
- EX-101.SCHsabs-20250926.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-220721-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLsabs-20250926_htm.xml
IDEA: XBRL DOCUMENT
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001833214
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 4:45 PM ET
- Size
- 495.6 KB